Clorox Co has rejected as too low an offer from billionaire investor Carl Icahn that values it at more than $10 billion. The company also adopted a poison pill to make an unwanted takeover more expensive. “We’re certainly not opposed to a sale, just a steal,” said Clorox Chairman and Chief Executive Don Knauss, who told Reuters in a telephone interview that he had a “mutually respectful conversation” with Icahn earlier on Monday. Knauss declined to say what ...